Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | DHODH | Q02127 | 4/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carfentrazone-Ethyl SCHEMBL7589541 | 0.93 | ALDH1A1 (0.36) | TP53TDP1ALDH1A1CYP3A4POLB | |
| Carfentrazone-Ethyl SCHEMBL7581322 | 0.93 | TP53 (0.38) | TP53DHODH | |
| Carfentrazone-Ethyl SCHEMBL7584978 | 0.91 | TP53 (0.49) | TP53TDP1ALDH1A1CYP3A4POLB | |
| Carfentrazone-Ethyl SCHEMBL7581556 | 0.89 | ALDH1A1 (0.33) | TP53TDP1ALDH1A1CYP3A4 | |
| Carfentrazone-Ethyl SCHEMBL7581812 | 0.88 | MAPT (0.36) | ALDH1A1DHODHMEN1KMT2A | |
| Carfentrazone-Ethyl SCHEMBL7579166 | 0.88 | ALDH1A1 (0.32) | TP53TDP1ALDH1A1CYP3A4 | |
| Carfentrazone-Ethyl SCHEMBL7585254 | 0.88 | ALDH1A1 (0.34) | TP53TDP1ALDH1A1CYP3A4 | |
| Carfentrazone-Ethyl SCHEMBL7585700 | 0.86 | TP53 (0.40) | TP53TDP1ALDH1A1CYP3A4POLB | |
| Carfentrazone-Ethyl SCHEMBL7581357 | 0.86 | TP53 (0.36) | TP53DHODH | |
| Carfentrazone-Ethyl SCHEMBL7588426 | 0.86 | TP53 (0.33) | TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | SYNGENTA PARTICIPATIONS AG (CH) | 2002-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020004457-A1 | Herbicidal composition | PPOX, ALAD, DDT | TP53 4303/4885TDP1 1969/4885ALDH1A1 812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.